-transparent.png){kind=logo}
Administration of zidovudine (ZDV or azidothymidine) to pregnant women with HIV infection may be of benefit to both the mother and her unborn child. Since pregnancy can have a substantial effect on the pharmacokinetics of a drug, the effect of pregnancy on the pharmacokinetics of ZDV (10 mg/kg, i.v. bolus) was studied in the macaque (Macaca nemestrina). The plasma clearance, steady-state volume of distribution, and terminal half-life of ZDV were found not to be significantly affected by pregnancy. Based on these findings, we predict that the pharmacokinetics of ZDV in women will not be affected by pregnancy. If this prediction is found to be correct, the dose of ZDV need not be adjusted when the drug is administered to pregnant women.
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
August 1989,
Pharmaceutical research,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
July 1992,
American journal of perinatology,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
September 1989,
American journal of obstetrics and gynecology,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
September 1987,
Annals of internal medicine,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
January 1990,
The American journal of the medical sciences,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
May 1998,
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
November 1993,
Medicina clinica,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
March 1990,
AIDS (London, England),
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
February 1994,
Journal of acquired immune deficiency syndromes,
A Lopez-Anaya, and
J D Unadkat, and
L A Schumann, and
A L Smith
January 1991,
Journal of acquired immune deficiency syndromes,
